Predictors of mortality amongst recipients of implantable cardioverter defibrillators for secondary prevention of cardiac arrest

Indian Pacing and Electrophysiology Journal

Volumn 7, Issue 4, 2007, Pages 218-224

  Agarwal, Sunil K ^a   Singla, Ish ^a   Hreybe, Haitham ^a   Saba, Samir ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cardiac arrest; Implantable cardioverter defibrillators; Mortality; Predictors

Indexed keywords

CREATININE;

ADULT; AGE; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEFIBRILLATOR; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ARREST; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PROPORTIONAL HAZARDS MODEL; QRS COMPLEX; RECIPIENT; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY PREVENTION; SURVIVAL RATE; TIME; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 36249008611     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Zipes, D.P. and Wellens, H.J. Sudden cardiac death. Circulation, 1998. 98:2334-51.
2. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med, 1997. 337:1576-83.
3. Connolly, S.J., et al., Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 2000. 101:1297-302.
4. Siebels, J. and Kuck K.H. Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J, 1994. 127:1139-44.
5. Olshansky, B., et al., Where patients with mild to moderate head failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J, 2007. 153:1089-94.
6. Bryant, J., et al., Clinical effectiveness and cost-effectiveness of implantable cardioverter defibrillators for arrhythmias: a systematic review and economic, evaluation. Int J Technol Assess Health Care, 2007. 23:63-70.
7. Chen, H.A., et al., The effect of gender on mortality or appropriate shock in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators.. Pacing Clin Electrophysiol, 2007. 30:390-4.
8. Dickinson, M.G., et al., Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J, 2007. 153:573-8.
9. Goldenberg, I., et al., Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol, 2007. 49:1427-33.
10. Henyan, N.N., et al., The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death. J Intern Méd, 2006. 260: 467-73.
11. Lee, D.S., et al., Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol, 2007. 49: 2408-15.
12. Tandri, H., et al., Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm, 2006. 3: 762-8.
13. Wase, A., et al., Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol, 2004. 11: 199-204.
14. Chen-Scarabelli, C. and Scarabelli T.M., Chronic renal insufficiency is an independent predictor of mortality in implantable cardioverter-defibrillator recipients. Pacing Clin Electrophysiol, 2007. 30: 371-6.
15. Turakhia, M.P., et al., Impact of renal function on survival in patients with implantable cardioverter-defibrillators. Pacing Clin Electrophysiol, 2007. 30: 377-84.
16. Cuculich, P.S., et al., Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol, 2007. 30: 207-13.
17. Stecker, E.C., et al., Native QRS duration predicts the occurrence of arrhythmic events in ICD recipients. Europace, 2006. 8: 859-62.
18. Bruch, C., et al., Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter-defibrillator. Europace, 2007, 9: 681-6.
19. Bode-Schnurbus, L., et al., QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart, 2003.89: 1157-62.
20. Grines, C.L., et al., Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation, 1989. 79: 845-53.
21. Xiao, H.B., Brecker S.J., and Gibson D.G., Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy. Br Heart J, 1992. 68: 403-7.